Funded Projects

Browse wide-ranging research at the frontiers of neuroscience supported by Wu Tsai Neurosciences Institute grants, awards, and training fellowships.

Wu Tsai Neurosciences Institute
Neuroscience:Translate Award
2022
Development of an extracochlear neurostimulation device to restore hearing – Renewal

Sensorineural hearing loss is an increasingly prevalent condition that causes disability to over a third of US adults aged over 65. This team is developing a breakthrough device to restore high-frequency hearing that preserves residual hearing through a reversible and minimally invasive approach.

Wu Tsai Neurosciences Institute
Neuroscience:Translate Award
2022
Remote reliable measurements of movement using bluetooth enabled engineered keyboard for diagnosis of neurological diseases - Renewal

This team is developing a device that will enable accurate diagnosis of Parkinson’s disease via telemedicine. They initially introduced the technology of Quantitative DigitoGraphy (QDG) using a repetitive alternating finger tapping (RAFT) task on a musical instrument digital interface (MIDI) keyboard and will use Neuroscience: Translate funding for the next stage of device development.

Wu Tsai Neurosciences Institute
SIGF - Graduate Fellowship
2022
Leveraging screenomics to identify mental illness: Detecting bipolar disorder through computational analysis of smartphone screen data

Mental illnesses like bipolar disorder affect millions of people around the world, but early symptoms are often difficult to detect. Working across the disciplines of clinical psychology, communication, and computer science, my research will develop a novel computational tool to identify signals of mania and depression in real-time.

Wu Tsai Neurosciences Institute
SIGF - Graduate Fellowship
2022
Mechanistic insights into glycerophospholipid metabolism in the lysosome

Phospholipid dysregulation is implicated in the pathogenesis of lysosomal storage disorders (LSDs). We found that glycerophosphodiesters (GPDs) accumulate in lysosomes derived from Batten disease models, a life-limiting LSD whose pathological mechanism remains elusive. GPDs are the degradation products of glycerophospholipid catabolism by phospholipases.